Immix Biopharma to Host Conference Call for Investors, Analysts and Members of the Media
- Company management will provide an update on positive new developments regarding…
Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients
December 08, 2024 12:00 ET | Source: Affimed N.V. The combination of…
Cogent Biosciences Announces Positive Updated Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
December 08, 2024 12:00 ET | Source: Cogent Biosciences, Inc. 52% ORR…
Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3…
Incyte Announces Positive Results from Phase 3 Trial Evaluating Retifanlimab (Zynyz) in Combination with Platinum-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer
— Phase 3 POD1UM-304 trial met primary endpoint of overall survival (OS)…
NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis
MILAN, Dec. 5, 2024 /PRNewswire/ -- NTC, an international R&D focused pharmaceutical…
TraceLink Announces Grant Recipients Driving Impact Across the Globe
BOSTON, Dec. 3, 2024 /PRNewswire/ -- TraceLink, the largest end-to-end digital network…
MACH CONFERENCES REPORTS STRONG SALES GROWTH AND POSITIVE OUTLOOK FOR H2 FY 2025
NEW DELHI, Dec. 2, 2024 /PRNewswire/ -- MACH CONFERENCES AND EVENTS LIMITED…
AsiaPay Champions Women-Led Ventures Across APAC with A$40K in Prizes
Second Year of Support for Women Entrepreneurs Driving Positive Change MELBOURNE, Australia,…
White Ribbon Day, 25th November: #ItStartswithMen to prevent violence against women and girls
Tuesday 19 November, 2024 White Ribbon Day, 25th November, will be marked…
